Moxifloxacin Hydrochloride Patent Expiration
Moxifloxacin Hydrochloride is Used for treating bacterial infections in patients. It was first introduced by Bayer Healthcare Pharmaceuticals Inc
Moxifloxacin Hydrochloride Patents
Given below is the list of patents protecting Moxifloxacin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Moxeza | US8450311 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug | May 29, 2029 | Harrow Eye |
| Moxeza | US9114168 | Pharmaceutical compositions containing a fluoroquinolone antibiotic drug | May 29, 2029 | Harrow Eye |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US6548079 | Moxifloxacin formulation containing common salt |
Jul 25, 2020
(Expired) | Bayer Hlthcare |
| Moxeza |
US6716830 (Pediatric) | Ophthalmic antibiotic compositions containing moxifloxacin |
Mar 29, 2020
(Expired) | Harrow Eye |
| Moxeza |
US7671070 (Pediatric) | Method of treating ophthalmic infections with moxifloxacin compositions |
Mar 29, 2020
(Expired) | Harrow Eye |
| Vigamox |
US6716830 (Pediatric) | Ophthalmic antibiotic compositions containing moxifloxacin |
Mar 29, 2020
(Expired) | Harrow Eye |
| Vigamox |
US7671070 (Pediatric) | Method of treating ophthalmic infections with moxifloxacin compositions |
Mar 29, 2020
(Expired) | Harrow Eye |
| Avelox | US6610327 | Pharmaceutical moxifloxacin preparation |
Oct 29, 2019
(Expired) | Bayer Hlthcare |
| Moxeza | US6716830 | Ophthalmic antibiotic compositions containing moxifloxacin |
Sep 29, 2019
(Expired) | Harrow Eye |
| Moxeza | US7671070 | Method of treating ophthalmic infections with moxifloxacin compositions |
Sep 29, 2019
(Expired) | Harrow Eye |
| Vigamox | US6716830 | Ophthalmic antibiotic compositions containing moxifloxacin |
Sep 29, 2019
(Expired) | Harrow Eye |
| Vigamox | US7671070 | Method of treating ophthalmic infections with moxifloxacin compositions |
Sep 29, 2019
(Expired) | Harrow Eye |
| Avelox | US5849752 | Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification |
Dec 05, 2016
(Expired) | Bayer Hlthcare |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US5849752 | Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification |
Dec 05, 2016
(Expired) | Bayer Hlthcare |
| Moxeza |
US5607942 (Pediatric) | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Sep 04, 2014
(Expired) | Harrow Eye |
| Vigamox |
US5607942 (Pediatric) | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Sep 04, 2014
(Expired) | Harrow Eye |
| Avelox | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Bayer Hlthcare |
| Avelox In Sodium Chloride 0.8% In Plastic Container | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Bayer Hlthcare |
| Moxeza | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Harrow Eye |
| Vigamox | US5607942 | 7-(1-pyrrolidinyl)-3-quinolone- and - naphthyridone-carboxylic acid derivatives as antibacterial agents and feed additives |
Mar 04, 2014
(Expired) | Harrow Eye |
Moxifloxacin Hydrochloride's Family Patents
